In early October, we hosted a gathering of scientists and researchers working on pancreatic cancer at UCLA, highlighting some of our recent Seed Grant awardees. With the goal to share […]
New insights into pancreatic cancer drug resistance and metastasis
Ethan V. Abel, PhD, a 2021 Seed Grant recipient at Roswell Park Comprehensive Cancer Center, has provided an update on his research in deciphering the role of the HNF1A-SKP2 axis […]
Pivotal research on RNA splicing may hold key to treatment
As we celebrate summer and all that is blooming, we look back at seeds planted through our Seed Grant Program, and are optimistic about the progress being made in pancreatic […]
New research on enzyme MMP-7 holds potential for drug development
As we celebrate spring and the blooms to come, we are looking back at seeds planted through our Seed Grant Program, and are optimistic about the progress being made in […]
Understanding Early Tumor Progression Through Tuft Cells
One of the main ways to improve the outcomes for pancreatic cancer patients is early diagnosis and the way to better diagnostics is through a greater understanding of the initiating […]
UCLA Researchers Receive Over $6M from NIH to Study Potential Immunotherapies for Pancreatic Cancer
Research teams at UCLA have received two grants from the National Institutes of Health (NIH), totaling over $6 million dollars to study the immunobiology of pancreatic tumors and develop a […]